Article(id=1330224889740505952, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.01.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1634054400000, receivedDateStr=2021-10-13, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795079928096, onlineDateStr=2026-11-19, pubDate=1641744000000, pubDateStr=2022-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795079928096, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795079928096, creator=13701087609, updateTime=1795079928096, updator=13701087609, issue=Issue{id=1330224864159445597, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='1', pageStart='1', pageEnd='104', issueExtLink='null', onlineDate='null', pubDate='1641744000000', pubDateStr='2022-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079921998, creator='13701087609', updateTime=1795084657767, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244727875678840, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244727875678841, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=15, endPage=18, ext={EN=ArticleExt(id=1330224891254649697, articleId=1330224889740505952, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=New progress on belizumab in the treatment of systemic lupus erythematosus, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Systemic lupus erythematosus (SLE) is a chronic diffuse connective tissue disease involving multiple systems of the whole body. The etiology and mechanism are not completely clear. At present, the treatment of SLE is still dominated by traditional drugs, such as non steroidal anti-inflammatory drugs, glucocorticoids and immunosuppressants, etc. In recent years, with the continuous improvement of the level of molecular targeted therapy, relevant academic circles have begun to pay extensive attention to biological agent therapy. Compared with traditional treatment methods, biological agents have a selective effect on self reactive lymphocytes or inflammatory mediators, which can reduce the damage of immune function and the incidence of adverse reactions. Belizumab is a medical biological agent and the first inhibitor of B lymphocyte stimulating factor. This paper reviewed the new progress of belizumab in the treatment of SLE, in order to provide reference for clinical diagnosis and treatment.

, authors=Qingling YANG1, 2, Guangtao XIA2, *, authorsList=Qingling YANG, Guangtao XIA, authorCompany=null, correspAuthors=Guangtao XIA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330224891464364898, articleId=1330224889740505952, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=贝利尤单抗在系统性红斑狼疮治疗中的新进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种可累及全身多系统的慢性弥漫性结缔组织疾病,病因机制尚不完全明确。目前,SLE治疗方案仍以传统治疗药物为主,例如非甾体抗炎药、糖皮质激素及免疫抑制剂等。近年来,随着分子靶向治疗水平的不断提高,生物制剂治疗受到广泛关注,与传统治疗方法相比,生物制剂对自身反应性淋巴细胞或炎症介质的作用具有可选择性,可降低机体免疫功能损害及不良反应发生率。贝利尤单抗(belizumab)作为一种医用生物制剂,是首个作用于B淋巴细胞刺激因子的抑制剂。现就贝利尤单抗在SLE治疗中的新进展作一综述,以期为临床诊治提供参考。

, authors=杨庆玲1, 2, 夏光涛2, *, authorsList=杨庆玲, 夏光涛, authorCompany=null, correspAuthors=夏光涛, authorNote=

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

, correspAuthorsNote=
夏光涛,主任医师,研究方向:风湿免疫病诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=MIFLDQ5pPhEsgCzAhV0aCg==, magXml=CAqq0dOBeW/+4jKKt6p+aw==, pdfUrl=null, pdf=kYrkcE0UNZNTJ5UqKSn07w==, pdfFileSize=1627486, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=V8iXH7mpv31xiV3/WdL85g==, mapNumber=null, fund=null)}, authors=[Author(id=1330224891825075052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330224891900572527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224891825075052, language=EN, stringName=Qingling YANG, firstName=Qingling, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China
2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224891963487088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224891825075052, language=CN, stringName=杨庆玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.寿光市中医医院风湿病科,山东 潍坊 262799
2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio={"content":"

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

"}, bioImg=null, bioContent=

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224891674080101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=1., ext=[AuthorCompanyExt(id=1330224891682468710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China), AuthorCompanyExt(id=1330224891690857319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.寿光市中医医院风湿病科,山东 潍坊 262799)]), AuthorCompany(id=1330224891753771880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=2., ext=[AuthorCompanyExt(id=1330224891762160489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224891766354794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])]), Author(id=1330224892018013042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330224892089316212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224892018013042, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224892152230773, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224892018013042, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224891753771880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=2., ext=[AuthorCompanyExt(id=1330224891762160489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224891766354794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])], keywords=[Keyword(id=1330224892231922550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=EN, orderNo=1, keyword=belizumab), Keyword(id=1330224892294837111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=EN, orderNo=2, keyword=systemic lupus erythematosus), Keyword(id=1330224892403889016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=EN, orderNo=3, keyword=biological agent), Keyword(id=1330224892466803577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=CN, orderNo=1, keyword=贝利尤单抗), Keyword(id=1330224892521329530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=CN, orderNo=2, keyword=系统性红斑狼疮), Keyword(id=1330224892617798523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, language=CN, orderNo=3, keyword=生物制剂)], refs=[Reference(id=1330224892810736509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Rees F, doherty M, Grainge MJ, et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies[J]. Rheumatology, 2017, 56(11): 1945-1961., articleTitle=null, refAbstract=null), Reference(id=1330224892882039678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185., articleTitle=null, refAbstract=null), Reference(id=1330224892940759935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Li M, Zhang W, Leng X, et al. Chinese SLE Treatment and Research Croup (CSTAR) registry: Ⅰ. major clinical characteristics of Chinese patients with systemic lupus erythematosus[J]. Lupus, 2013, 22(11): 1192-1199., articleTitle=null, refAbstract=null), Reference(id=1330224892995285888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang S, Su J, Li X, et al. Chinese SLE Treatment and Research Croup (CSTAR) registry: Ⅴ. gender impact on Chinese patients with systemic lupus erythematosus[J]. Lupus, 2015, 24(12): 1267-1275., articleTitle=null, refAbstract=null), Reference(id=1330224893058200449, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang J, Pospisil R, Ray S, et al. Investigations of a rabbit (Orye-tolagns eunieulus) model of systemic lupus erythematosus (SLE), BAFF and its receptors[J]. PLoS One, 2009, 4(12): e8494., articleTitle=null, refAbstract=null), Reference(id=1330224893116920706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Dennis GJ. Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus[J]. Clin Pharmacol Ther, 2012, 91(1): 143-149., articleTitle=null, refAbstract=null), Reference(id=1330224893192418179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Wiglesworth AK, Ennis KM, Kockler DR. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus[J]. Ann Pharmacother, 2010, 44(12): 1955-1961., articleTitle=null, refAbstract=null), Reference(id=1330224893263721348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Tocoian A, Buchan P, Kirby H, et al. First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus[J]. Lupus, 2015, 24(10): 1045-1056., articleTitle=null, refAbstract=null), Reference(id=1330224893318247301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Navarra SV, Guzman RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial[J]. Lancet, 2011, 377(9767): 721-731., articleTitle=null, refAbstract=null), Reference(id=1330224893381161862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Furie R, Petri M, Zamani O, et al. A phase Ⅲ, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus[J]. Arthritis Rheum, 2011, 63(12): 3918-3930., articleTitle=null, refAbstract=null), Reference(id=1330224893469242247, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Dooley MA, Houssiau F, Aranow C, et al. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE[J]. Lupus, 2013, 22(1): 63-72., articleTitle=null, refAbstract=null), Reference(id=1330224893532156808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Strand V, Levy RA, Cervera R, et al. Improvements in health-related quality of life with belimumab a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials[J]. Ann Rheum Dis, 2014, 73(5): 838-844., articleTitle=null, refAbstract=null), Reference(id=1330224893616042889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Sciascia S, Talavera-Garcia E, Roccatello D, et al. Upcoming biological therapies in systemic lupus erythematosus[J]. Int lmmunopharmaeol, 2015, 27(2): 189-193., articleTitle=null, refAbstract=null), Reference(id=1330224893687346058, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Wallace DJ, Ginzler EM, Merrill JT, et al. Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus[J]. J Rheumatol, 2014, 41(2): 300-309., articleTitle=null, refAbstract=null), Reference(id=1330224893741872011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Bruce IN, Urowitz M, van Vollenhoven R, et al. Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care[J]. Lupus, 2016, 25(7): 699-709., articleTitle=null, refAbstract=null), Reference(id=1330224893804786572, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Stohl W, Schwarting A, Okada M, et al. Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: a fifty-two-week randomized, double-blind, placebo-controlled study[J]. Arthritis Rheumatol, 2017, 69(5): 1016-1027., articleTitle=null, refAbstract=null), Reference(id=1330224893876089741, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=张凌霄, 李婷, 许羚, 等. 贝利木单抗治疗系统性红斑狼疮的模型化疗效评[J]. 中国临床药理学与治疗学, 2021, 26(2): 174-181., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330224892718461820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, awardId=ZR2021MH265, language=CN, fundingSource=山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330224891674080101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=1., ext=[AuthorCompanyExt(id=1330224891682468710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China), AuthorCompanyExt(id=1330224891690857319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.寿光市中医医院风湿病科,山东 潍坊 262799)]), AuthorCompany(id=1330224891753771880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=2., ext=[AuthorCompanyExt(id=1330224891762160489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224891766354794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.01.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.01.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1641744000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
贝利尤单抗在系统性红斑狼疮治疗中的新进展
杨庆玲 1, 2 , 夏光涛 2, *
世界临床药物 | 医药专论 2022,43(1): 15-18
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (1) : 15 -18
贝利尤单抗在系统性红斑狼疮治疗中的新进展
全屏
[Author(id=1330224891825075052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330224891900572527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224891825075052, language=EN, stringName=Qingling YANG, firstName=Qingling, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China
2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224891963487088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224891825075052, language=CN, stringName=杨庆玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.寿光市中医医院风湿病科,山东 潍坊 262799
2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio={"content":"

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

"}, bioImg=null, bioContent=

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224891674080101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=1., ext=[AuthorCompanyExt(id=1330224891682468710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China), AuthorCompanyExt(id=1330224891690857319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891674080101, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.寿光市中医医院风湿病科,山东 潍坊 262799)]), AuthorCompany(id=1330224891753771880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=2., ext=[AuthorCompanyExt(id=1330224891762160489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224891766354794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])]), Author(id=1330224892018013042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330224892089316212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224892018013042, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224892152230773, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, authorId=1330224892018013042, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224891753771880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, xref=2., ext=[AuthorCompanyExt(id=1330224891762160489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224891766354794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224889740505952, companyId=1330224891753771880, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])]
杨庆玲1, 2, 夏光涛2, *
作者信息
  • 1.寿光市中医医院风湿病科,山东 潍坊 262799
  • 2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021
通讯作者:
夏光涛,主任医师,研究方向:风湿免疫病诊治。
作者简介:

杨庆玲,硕士研究生,研究方向:风湿免疫病诊治。

New progress on belizumab in the treatment of systemic lupus erythematosus
Qingling YANG1, 2, Guangtao XIA2, *
Affiliations
  • 1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China
  • 2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
出版时间: 2022-01-10 doi: 10.13683/j.wph.2022.01.004
文章导航
收藏切换

系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种可累及全身多系统的慢性弥漫性结缔组织疾病,病因机制尚不完全明确。目前,SLE治疗方案仍以传统治疗药物为主,例如非甾体抗炎药、糖皮质激素及免疫抑制剂等。近年来,随着分子靶向治疗水平的不断提高,生物制剂治疗受到广泛关注,与传统治疗方法相比,生物制剂对自身反应性淋巴细胞或炎症介质的作用具有可选择性,可降低机体免疫功能损害及不良反应发生率。贝利尤单抗(belizumab)作为一种医用生物制剂,是首个作用于B淋巴细胞刺激因子的抑制剂。现就贝利尤单抗在SLE治疗中的新进展作一综述,以期为临床诊治提供参考。

贝利尤单抗  /  系统性红斑狼疮  /  生物制剂

Systemic lupus erythematosus (SLE) is a chronic diffuse connective tissue disease involving multiple systems of the whole body. The etiology and mechanism are not completely clear. At present, the treatment of SLE is still dominated by traditional drugs, such as non steroidal anti-inflammatory drugs, glucocorticoids and immunosuppressants, etc. In recent years, with the continuous improvement of the level of molecular targeted therapy, relevant academic circles have begun to pay extensive attention to biological agent therapy. Compared with traditional treatment methods, biological agents have a selective effect on self reactive lymphocytes or inflammatory mediators, which can reduce the damage of immune function and the incidence of adverse reactions. Belizumab is a medical biological agent and the first inhibitor of B lymphocyte stimulating factor. This paper reviewed the new progress of belizumab in the treatment of SLE, in order to provide reference for clinical diagnosis and treatment.

belizumab  /  systemic lupus erythematosus  /  biological agent
杨庆玲, 夏光涛. 贝利尤单抗在系统性红斑狼疮治疗中的新进展. 世界临床药物, 2022 , 43 (1) : 15 -18 . DOI: 10.13683/j.wph.2022.01.004
Qingling YANG, Guangtao XIA. New progress on belizumab in the treatment of systemic lupus erythematosus[J]. World Clinical Drug, 2022 , 43 (1) : 15 -18 . DOI: 10.13683/j.wph.2022.01.004
  • 山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265)
参考文献 引证文献
排序方式:
[1]
Rees F, doherty M, Grainge MJ, et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies[J]. Rheumatology, 2017, 56(11): 1945-1961.
[2]
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185.
[3]
Li M, Zhang W, Leng X, et al. Chinese SLE Treatment and Research Croup (CSTAR) registry: Ⅰ. major clinical characteristics of Chinese patients with systemic lupus erythematosus[J]. Lupus, 2013, 22(11): 1192-1199.
[4]
Zhang S, Su J, Li X, et al. Chinese SLE Treatment and Research Croup (CSTAR) registry: Ⅴ. gender impact on Chinese patients with systemic lupus erythematosus[J]. Lupus, 2015, 24(12): 1267-1275.
[5]
Yang J, Pospisil R, Ray S, et al. Investigations of a rabbit (Orye-tolagns eunieulus) model of systemic lupus erythematosus (SLE), BAFF and its receptors[J]. PLoS One, 2009, 4(12): e8494.
[6]
Dennis GJ. Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus[J]. Clin Pharmacol Ther, 2012, 91(1): 143-149.
[7]
Wiglesworth AK, Ennis KM, Kockler DR. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus[J]. Ann Pharmacother, 2010, 44(12): 1955-1961.
[8]
Tocoian A, Buchan P, Kirby H, et al. First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus[J]. Lupus, 2015, 24(10): 1045-1056.
[9]
Navarra SV, Guzman RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial[J]. Lancet, 2011, 377(9767): 721-731.
[10]
Furie R, Petri M, Zamani O, et al. A phase Ⅲ, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus[J]. Arthritis Rheum, 2011, 63(12): 3918-3930.
[11]
Dooley MA, Houssiau F, Aranow C, et al. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE[J]. Lupus, 2013, 22(1): 63-72.
[12]
Strand V, Levy RA, Cervera R, et al. Improvements in health-related quality of life with belimumab a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials[J]. Ann Rheum Dis, 2014, 73(5): 838-844.
[13]
Sciascia S, Talavera-Garcia E, Roccatello D, et al. Upcoming biological therapies in systemic lupus erythematosus[J]. Int lmmunopharmaeol, 2015, 27(2): 189-193.
[14]
Wallace DJ, Ginzler EM, Merrill JT, et al. Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus[J]. J Rheumatol, 2014, 41(2): 300-309.
[15]
Bruce IN, Urowitz M, van Vollenhoven R, et al. Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care[J]. Lupus, 2016, 25(7): 699-709.
[16]
Stohl W, Schwarting A, Okada M, et al. Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: a fifty-two-week randomized, double-blind, placebo-controlled study[J]. Arthritis Rheumatol, 2017, 69(5): 1016-1027.
[17]
张凌霄, 李婷, 许羚, 等. 贝利木单抗治疗系统性红斑狼疮的模型化疗效评[J]. 中国临床药理学与治疗学, 2021, 26(2): 174-181.
2022年第43卷第1期
14
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.01.004
  • 接收时间:2021-10-13
  • 首发时间:2026-11-19
  • 出版时间:2022-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-10-13
基金
山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265)
作者信息
    1.寿光市中医医院风湿病科,山东 潍坊 262799
    2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021

通讯作者:

夏光涛,主任医师,研究方向:风湿免疫病诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏